4.7 Article

Chronic lymohocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Journal

ANNALS OF ONCOLOGY
Volume 32, Issue 1, Pages 23-33

Publisher

ELSEVIER
DOI: 10.1016/j.annonc.2020.09.019

Keywords

chronic lymphocytic leukaemia; prognostic factors; individualised therapy; B-cell receptor inhibitors; BCL2 inhibitor; targeted treatment

Categories

Funding

  1. ESMO from central funds

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available